Amol R. Rao

Oncology

18111 Brookhurst St Ste 6100
Fountain Valley, CA 92708

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.

Journal: Cancer

Published: March 16, 2017

Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.

Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.

Journal: Cancer immunology research

Published: May 06, 2014

Showing 1-2 of 2

Last Updated: 09/26/2026